Illumina INC (ILMN) Shares Rose While Hitchwood Capital Management LP Has Boosted Holding by $9.61 Million

Illumina, Inc. (NASDAQ:ILMN) LogoInvestors sentiment increased to 1.53 in Q2 2018. Its up 0.18, from 1.35 in 2018Q1. It increased, as 26 investors sold ILMN shares while 175 reduced holdings. 87 funds opened positions while 221 raised stakes. 128.56 million shares or 1.04% less from 129.91 million shares in 2018Q1 were reported. Hitchwood Capital Ltd Partnership holds 3.89% in Illumina, Inc. (NASDAQ:ILMN) or 444,458 shares. Bamco Inc holds 429,790 shares or 0.52% of its portfolio. Moreover, Tci Wealth Advsr has 0.04% invested in Illumina, Inc. (NASDAQ:ILMN) for 346 shares. Teachers Retirement System Of The State Of Kentucky invested 0.05% of its portfolio in Illumina, Inc. (NASDAQ:ILMN). Rafferty Asset Mngmt Limited Company has invested 0.02% in Illumina, Inc. (NASDAQ:ILMN). Trexquant Inv LP invested in 6,049 shares or 0.12% of the stock. Swiss Comml Bank holds 486,045 shares. Eagle Asset Mngmt stated it has 308,210 shares. State Of New Jersey Common Pension Fund D holds 0.19% of its portfolio in Illumina, Inc. (NASDAQ:ILMN) for 180,000 shares. 104,740 are held by Great West Life Assurance Can. Fifth Third Bank accumulated 0% or 408 shares. First Mercantile Tru Commerce owns 4,015 shares for 0.22% of their portfolio. Comerica State Bank holds 0.09% or 41,106 shares. Birch Hill Invest Advsr Ltd invested 0.02% in Illumina, Inc. (NASDAQ:ILMN). Rampart Mngmt Company Ltd holds 0.28% of its portfolio in Illumina, Inc. (NASDAQ:ILMN) for 10,256 shares.

Since June 11, 2018, it had 0 buys, and 24 insider sales for $24.21 million activity. deSouza Francis A had sold 2,100 shares worth $652,788 on Thursday, November 1. Another trade for 10,000 shares valued at $3.47 million was made by Ronaghi Mostafa on Monday, September 10. FLATLEY JAY T had sold 3,300 shares worth $1.02 million. 644 shares were sold by OSTADAN OMEAD, worth $197,541. The insider Stapley Marc sold 1,000 shares worth $352,054. Shares for $386,410 were sold by Van Oene Mark on Tuesday, September 4.

Hitchwood Capital Management Lp increased its stake in Illumina Inc (ILMN) by 8.4% based on its latest 2018Q2 regulatory filing with the SEC. Hitchwood Capital Management Lp bought 34,458 shares as the company’s stock rose 21.79% with the market. The institutional investor held 444,458 shares of the capital goods company at the end of 2018Q2, valued at $124.13 million, up from 410,000 at the end of the previous reported quarter. Hitchwood Capital Management Lp who had been investing in Illumina Inc for a number of months, seems to be bullish on the $47.25 billion market cap company. The stock decreased 3.86% or $12.91 during the last trading session, reaching $321.41. About 1.08M shares traded or 0.85% up from the average. Illumina, Inc. (NASDAQ:ILMN) has risen 63.52% since December 8, 2017 and is uptrending. It has outperformed by 47.90% the S&P500.

Hitchwood Capital Management Lp, which manages about $657.83M and $3.19 billion US Long portfolio, decreased its stake in Guidewire Software Inc (NYSE:GWRE) by 55,100 shares to 350,000 shares, valued at $31.07 million in 2018Q2, according to the filing. It also reduced its holding in Netflix Inc (NASDAQ:NFLX) by 250,000 shares in the quarter, leaving it with 100,000 shares, and cut its stake in Gds Hldgs Ltd.

More notable recent Illumina, Inc. (NASDAQ:ILMN) news were published by: Nasdaq.com which released: “Here’s Why Investors Should Hold AngioDynamics Stock Now – Nasdaq” on December 07, 2018, also Streetinsider.com with their article: “Illumina (ILMN) Announces Launch of New High-Density Genotyping Array – StreetInsider.com” published on December 06, 2018, Nasdaq.com published: “HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q3 – Nasdaq” on December 05, 2018. More interesting news about Illumina, Inc. (NASDAQ:ILMN) were released by: Nasdaq.com and their article: “Medtronic Gets Health Canada License for Visualase System – Nasdaq” published on November 23, 2018 as well as Fool.com‘s news article titled: “Here’s Why Illumina’s $1.2 Billion Acquisition Makes Sense – The Motley Fool” with publication date: November 14, 2018.

Illumina, Inc. (NASDAQ:ILMN) Ratings Coverage

Among 8 analysts covering Illumina (NASDAQ:ILMN), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Illumina had 11 analyst reports since June 25, 2018 according to SRatingsIntel. Morgan Stanley maintained Illumina, Inc. (NASDAQ:ILMN) rating on Friday, July 13. Morgan Stanley has “Underweight” rating and $210 target. Barclays Capital maintained it with “Overweight” rating and $350 target in Tuesday, July 31 report. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, July 31. Barclays Capital maintained it with “Overweight” rating and $370 target in Wednesday, October 24 report. The rating was maintained by Citigroup on Tuesday, July 31 with “Buy”. The stock of Illumina, Inc. (NASDAQ:ILMN) earned “Buy” rating by Citigroup on Monday, June 25. On Tuesday, July 10 the stock rating was maintained by Cowen & Co with “Outperform”. The rating was maintained by PiperJaffray on Tuesday, July 17 with “Overweight”. As per Tuesday, August 7, the company rating was upgraded by Morgan Stanley. The stock has “Buy” rating by Argus Research on Friday, August 10.

Illumina, Inc. (NASDAQ:ILMN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.